Abstract: The present invention relates to salts, polymorphs and hydrates of 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.

Abstract: The present invention relates to salts, polymorphs and hydrates of 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.

Abstract: This invention relates to certain ceramide-analogues of FTY720 (2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; fingolimod). In particular, the present invention relates to pharmaceutical compositions comprising these compounds, as well as processes for their preparation and their use in the treatment of autoimmune conditions, such as multiple sclerosis.

Abstract: The present invention relates to crystalline forms and hydrates of 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.

Abstract: The present invention relates to crystalline forms and hydrates of 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.

Abstract: This invention relates to certain ceramide-analogues of FTY720 (2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; fingolimod). In particular, the present invention relates to pharmaceutical compositions comprising these compounds, as well as processes for their preparation and their use in the treatment of autoimmune conditions, such as multiple sclerosis.

Abstract: The present invention relates to crystalline forms and hydrates of 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.

Abstract: The present invention relates to salts, polymorphs and hydrates of 2-Amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diol, and to the use thereof, in particular in the treatment or prevention of various autoimmune conditions.

Abstract: Polymorphic crystal forms of 3-methylthiophene-2-carboxylic acid (6S,9R,10S,11S,13S,16R, 17R)-9-chloro-6-fluoro-11-hydroxy-17-methoxycarbonyl-10,13,16-trimethyl-3-oxo-6,7,8,9,10, 11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester. The crystal forms possess anti-inflammatory activity and have very good stability. Methods for preparing the crystal forms are also described.

Abstract: New polymorphic crystal form of (R)-5-[2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one maleate designated crystal form Qalpha that is useful in the treatment of inflammatory or obstructive airways diseases. A method for preparing crystal form Qalpha is also described.

Abstract: Polymorphic crystal forms of 3-methylthiophene-2-carboxylic acid (6S,9R,10S,11S,13S,16R,17R)-9-chloro-6-fluoro-11-hydroxy-17-methoxycarbonyl-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl ester. The crystal forms possess anti-inflammatory activity and have very good stability. Methods for preparing the crystal forms are also described.

Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.

Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.

Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.

Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.

Abstract: Disclosed is a process for the production of 2-amino-2-[2-(4-C2-20-alkyl-phenyl)ethyl]propane-1,3-diols.

Abstract: Dye mixtures comprising at least one dye of formula ##STR1## together with at least one dye of formula ##STR2## wherein R.sub.1 and R.sub.2 are each independently of the other hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.4 -alkanoylamino, halogen or sulfo,R.sub.3 is C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.4 alkanoylamino, halogen or sulfo, andY is C.sub.1 -C.sub.4 alkyl or phenyl or naphthyl, each of which is unsubstituted or substituted byC.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.4 alkanoylamino, halogen or sulfo, which dye mixtures contain at least 10% by weight of one or more than one dye of formula (1), based on the total amount of the dyes of formulae (1) and (2), dye nitrogen-containing or hydroxyl group-containing fiber materials with good properties.

Abstract: The invention relates to a process for the preparation of compounds of formula ##STR1## wherein R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl or sulfo, and R.sub.2 is hydrogen or C.sub.1 -C.sub.4 alkyl, which process comprises reacting a compound of formula ##STR2## wherein Hal is halogen and R.sub.1 has the meaning given above, with a compound of formula ##STR3## wherein Y is a saponifiable group and R.sub.2 has the meaning given above, to give the compound of formula ##STR4## wherein R.sub.1, R.sub.2 and Y have the meanings given above, and saponifying the compound of formula (4) to give the compound of formula (1).The compounds of formula (1) are suitable for the synthesis of dyes.

Abstract: A process for dyeing or printing polyamide material by the trichromatic technique using a dye mixture which contains least two yellow- or orange-dyeing dyes of formula (1) ##STR1## wherein R.sub.1 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen, and X is hydrogen or C.sub.1 -C.sub.4 alkyl; together with at least one red-dyeing dye of formulae (2) and (3) ##STR2## wherein R.sub.2 is C.sub.1 -C.sub.6 alkyl, phenyl or cyclohexyl and R.sub.3 is C.sub.1 -C.sub.6 alkyl, or wherein R.sub.2 and R.sub.3, together with the linking nitrogen atom, form an azepinyl ring, and R.sub.4 is hydrogen, C.sub.2 -C.sub.4 alkanoylamino or halogen; and together with at least one of the blue-dyeing dyes of formulae (4) and (5) ##STR3## wherein R.sub.5 is hydrogen or C.sub.1 -C.sub.4 alkyl, R.sub.6 is C.sub.1 -C.sub.4 alkyl or amino, R.sub.7 is hydrogen or methyl, and R.sub.8 is a C.sub.2-4 hydroxyalkylsulfamoyl radical, is disclosed.

Abstract: Reactive dyes of formula ##STR1## wherein R.sub.1 and R.sub.2 are each independently of the other hydrogen or C.sub.1 -C.sub.4 alkyl,R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are each independently of one another hydrogen, C.sub.1 -C.sub.4 alkyl,C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.4 alkanoylamino, ureido or halogen,X is chloro or fluoro,Z is a group of formula --CH.dbd.CH.sub.2 or --CH.sub.2 --CH.sub.2 --Y, and Y is a leaving group, andA is as defined in claim 1,are particularly suitable for dyeing or printing cellulosic fiber materials or natural or synthetic polyamide fiber materials in high tinctorial yield, and give dyeings and prints with good fastness properties.